We use cookies on this site to enhance your user experience

By clicking any link on this page you are giving your consent for us to set cookies.

Skip to main content
Home

Search form

  • ABOUT US
    • ECFS Society Details
      • Society Information
      • Applications for Support
    • ECFS Membership
      • Membership Subscription
      • Membership Demographics
    • Other Information
      • Latest News
      • Job Opportunities
      • Grants and Programmes
      • Links
  • RESEARCH
    • ECFS Projects
      • ECFS Clinical Trials Network
      • ECFS Patient Registry
    • ECFS Working Groups
      • Diagnostic Network
      • Exercise
      • Neonatal Screening
      • Fungal Pathogens
      • Pulmonary Exacerbation
    • Special Projects
      • ECFS / CF Europe Post-Doctoral Research Fellowship
      • CFQ-R questionnaire and CF candidates for lung transplant
      • EU funded projects
      • MucoFong International Project
      • Complete CFTR gene mutation analysis in European patients with Cystic Fibrosis
    • Past Working Groups
      • Cystic Fibrosis Molecular and Cell Biology and Physiology Basic Science
      • ECFS Gene Modifier Working Group
      • ECFS Non Tuberculous Mycobacteria Working Group
  • CARE
    • ECFS Standards Of Care
    • ECFS Working Groups
      • Exercise
      • Diagnostic Network
      • Neonatal Screening
      • Mental Health
      • Fungal Pathogens
      • Pulmonary Exacerbation
      • Telehealth
    • Allied Health Professionals
      • ECFS Nursing Special interest Group
      • European CF Pharmacy Group
      • European Cystic Fibrosis Nutrition Group
      • European Psychosocial Special Interest Group
      • ECFS Physiotherapy Special Interest International Group
  • EDUCATION
  • CONFERENCES & EVENTS
    • European Cystic Fibrosis Conference
    • ECFS Basic Science Conference
    • Related events
    • Past ECFS conferences
  • PUBLICATIONS
    • About Publications
      • The Journal of Cystic Fibrosis
      • ECFS Newsletter
      • ECFS Book
      • ERS Monograph
    • Resources
      • Search All Resources
      • CF Research News
      • Consensus Reports
      • ECFS Guidelines
      • Free Access Articles
      • CF Literature
  • MEMBERSHIP
  • LOG IN

CFRD

Standards for the care of people with cystic fibrosis (CF); recognising and addressing CF health issues

  • Read more about Standards for the care of people with cystic fibrosis (CF); recognising and addressing CF health issues

Beyond Insulin: Unraveling the Complex Interplay of Cell Stress and Cell Communication in CFRD

  • Read more about Beyond Insulin: Unraveling the Complex Interplay of Cell Stress and Cell Communication in CFRD

Effects of CFTR Modulators on Metabolic Parameters

  • Read more about Effects of CFTR Modulators on Metabolic Parameters

Can a new blood test be used to screen for CF-related diabetes ?

  • Read more about Can a new blood test be used to screen for CF-related diabetes ?

Lumacaftor/ivacaftor therapy fails to increase insulin secretion in F508del/F508del CF patients

  • Read more about Lumacaftor/ivacaftor therapy fails to increase insulin secretion in F508del/F508del CF patients

Peak OGTT glucose is associated with lower lung function in young children with cystic fibrosis.

  • Read more about Peak OGTT glucose is associated with lower lung function in young children with cystic fibrosis.

Peak OGTT glucose is associated with lower lung function in young children with cystic fibrosis.

  • Read more about Peak OGTT glucose is associated with lower lung function in young children with cystic fibrosis.

Peak OGTT glucose is associated with lower lung function in young children with cystic fibrosis.

  • Read more about Peak OGTT glucose is associated with lower lung function in young children with cystic fibrosis.

The main mechanism associated with progression of glucose intolerance in older patients with cystic fibrosis is insulin resistance and not reduced insulin secretion capacity.

  • Read more about The main mechanism associated with progression of glucose intolerance in older patients with cystic fibrosis is insulin resistance and not reduced insulin secretion capacity.

Update on cystic fibrosis-related diabetes

  • Read more about Update on cystic fibrosis-related diabetes
  • 1
  • 2
  • next
  • last
Terms & Conditions Privacy policy  Accessibility Sitemap Contact 
© EUROPEAN CYSTIC FIBROSIS SOCIETY 2025. All rights reserved. Website by VidaVia (link is external)
European Cystic Fibrosis Society (ECFS)